Literature DB >> 15601602

Resting neural activity distinguishes subgroups of schizophrenia patients.

Dolores Malaspina1, Jill Harkavy-Friedman, Cheryl Corcoran, Lilianne Mujica-Parodi, David Printz, Jack M Gorman, Ronald Van Heertum.   

Abstract

BACKGROUND: Schizophrenia is etiologically heterogeneous. It is anticipated, but unproven, that subgroups will differ in neuropathology and that neuroimaging may reveal these differences. The optimal imaging condition may be at rest, where greater variability is observed than during cognitive tasks, which more consistently reveal hypofrontality. We previously demonstrated symptom and physiologic differences between familial and sporadic schizophrenia patients and hypothesized that the groups would show different resting regional cerebral blood flow (rCBF) patterns.
METHODS: Ten familial and sixteen sporadic schizophrenia patients and nine comparison subjects had single photon emission computed tomography imaging during passive visual fixation. Images were spatially normalized into Talairach coordinates and analyzed for group rCBF differences using SPM with a Z value threshold of 2.80, p < .001.
RESULTS: The subgroups had similar age, gender, illness duration, and medication treatment. Sporadic patients had hypofrontality (anterior cingulate, paracingulate cortices, left dorsolateral and inferior-orbitofrontal), whereas familial patients had left temporoparietal hypoperfusion; all of these regions show resting activity in healthy subjects. Both groups hyperperfused the cerebellum/pons and parahippocampal gyrus; additional hyperperfusion for sporadic patients was observed in the fusiform; familial patients also hyperperfused the hippocampus, dentate, uncus, amygdala, thalamus, and putamen.
CONCLUSIONS: Familial and sporadic schizophrenia patients had different resting rCBF profiles, supporting the hypothesis that certain subgroups have distinct neural underpinnings. Different neuropathologic processes among subgroups of schizophrenia patients may account for the prior contradictory results of resting imaging studies.

Entities:  

Mesh:

Year:  2004        PMID: 15601602      PMCID: PMC2993017          DOI: 10.1016/j.biopsych.2004.09.013

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  50 in total

Review 1.  The neurobiology of social cognition.

Authors:  R Adolphs
Journal:  Curr Opin Neurobiol       Date:  2001-04       Impact factor: 6.627

Review 2.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

Review 3.  Interacting minds--a biological basis.

Authors:  C D Frith; U Frith
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

4.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

Authors:  L D Selemon; G Rajkowska; P S Goldman-Rakic
Journal:  Arch Gen Psychiatry       Date:  1995-10

5.  The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects.

Authors:  F M Benes; S L Vincent; M Todtenkopf
Journal:  Biol Psychiatry       Date:  2001-09-15       Impact factor: 13.382

Review 6.  Searching for a baseline: functional imaging and the resting human brain.

Authors:  D A Gusnard; M E Raichle; M E Raichle
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

Review 7.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

8.  The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging.

Authors:  E O'Callaghan; P Buckley; C Madigan; O Redmond; J P Stack; A Kinsella; C Larkin; J T Ennis; J L Waddington
Journal:  Biol Psychiatry       Date:  1995-10-15       Impact factor: 13.382

9.  Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls.

Authors:  B V Siegel; K H Nuechterlein; L Abel; J C Wu; M S Buchsbaum
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

10.  Smooth pursuit eye movement differences between familial and non-familial schizophrenia.

Authors:  B D Schwartz; B A O'Brien; W J Evans; F J Sautter; D K Winstead
Journal:  Schizophr Res       Date:  1995-10       Impact factor: 4.939

View more
  66 in total

1.  Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI.

Authors:  Amy Pinkham; James Loughead; Kosha Ruparel; Wen-Chau Wu; Eve Overton; Raquel Gur; Ruben Gur
Journal:  Psychiatry Res       Date:  2011-08-09       Impact factor: 3.222

2.  Resting brain activity varies with dream recall frequency between subjects.

Authors:  Jean-Baptiste Eichenlaub; Alain Nicolas; Jérôme Daltrozzo; Jérôme Redouté; Nicolas Costes; Perrine Ruby
Journal:  Neuropsychopharmacology       Date:  2014-01-16       Impact factor: 7.853

Review 3.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

4.  Paternal age related schizophrenia and cardiac autonomic regulation profiles.

Authors:  Daniel Antonius; David Kimhy; Jill Harkavy-Friedman; Sarah Crystal; Ray Goetz; Dolores Malaspina
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

Review 5.  Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling.

Authors:  Carol A Tamminga; Sarah Southcott; Carolyn Sacco; Anthony D Wagner; Subroto Ghose
Journal:  Schizophr Bull       Date:  2012-04-24       Impact factor: 9.306

6.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

Review 7.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

8.  Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.

Authors:  Scott A Schobel; Nashid H Chaudhury; Usman A Khan; Beatriz Paniagua; Martin A Styner; Iris Asllani; Benjamin P Inbar; Cheryl M Corcoran; Jeffrey A Lieberman; Holly Moore; Scott A Small
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

9.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

Review 10.  Hippocampal granule cell pathology in epilepsy - a possible structural basis for comorbidities of epilepsy?

Authors:  Michael S Hester; Steve C Danzer
Journal:  Epilepsy Behav       Date:  2014-01-24       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.